Press Releases

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood issued the following statement on the ruling issued today by the U.S. Supreme Court regarding the Affordable Care Act.

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. Senate.

The global event for biotechnology brings together industry leaders for networking, partnering, and deal-making.

The 73 to 26 vote against the amendment highlights the value the U.S. Congress places on science-based policymaking and the importance of agricultural innovation.

Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on unanimous passage of S. 3187, the Food and Drug Administration Safety and Innovation Act (FDASIA), by the U.S. House of Representatives.

The Biotechnology Industry Organization (BIO) released a report on the significant economic impact of university and non-profit institution patent licensing on the U.S. economy.

The world’s largest biotechnology event, 2012 BIO International Convention, showcased the global financial and business developments that are shaping the biotechnology sector during the Convention’s second day. 

The Biotechnology Industry Organization(BIO) unveiled a report on the role of intellectual property rights in encouraging upstream research and development as well as downstream commercialization of biotechnology at the 2012 BIO International Convention.

The 4th Annual Scientific American Worldview Report and Scorecard – the most comprehensive country-by-country analysis of biotechnology – reveals the parameters essential for building a successful biotechnology hub in today’s increasingly global industry.

Forty-one state bioscience organizations announce today the formation of the Coalition of State Bioscience Institutes to ensure America’s leadership in bioscience innovation.

The Biotechnology Institute announces today the formation of the nationally coordinated effort of state bioscience organizations. 

The Biotechnology Industry Organization (BIO) announced today that Margaret Foti, Ph.D., M.D. (h.c.), CEO of the American Association  for Cancer Research, has been selected as the Honoree for the 2012 Biotech Humanitarian Award.

BIO hosted two former Secretaries of the U.S. Treasury, Robert E. Rubin and Henry M. Paulson, Jr., during a luncheon keynote session where they discussed the current state and future prospects of the global economy.

The Board of Directors of BIO elected its Executive Committee and added new members to Section Governing Boards in a meeting held in conjunction with the 2012 BIO International Convention.

The 2012 BIO International Convention, the world’s largest biotechnology event, kicked off at the Boston Convention and Exhibition Center. 

The Biotechnology Industry Organization (BIO) will release three surveys providing insight into voter attitudes, the opinions of biotech executives and the thoughts of those attending the 2012 BIO International Convention. 

Fifth biennial report by Battelle outlines 6.4% job growth in sector from 2001 to 2010, while overall economy recorded a 2.9% decline in jobs.

Ten of the brightest young minds in biotech have won the U.S. National BioGENEius Challenge.

The 4th Annual Scientific American Worldview Report and Scorecard - the most comprehensive country-by-country analysis of biotechnology - reveals the parameters essential for building a successful biotechnology hub in today's increasingly global industry.

BIO will host a phone briefing during the 2012 BIO International Convention that will provide a global perspective on the latest biotechnology developments shaping nations around the world.

This BIO Buzz Center event will feature Dr. Catherine Woteki, USDA’s Under Secretary for Research, Education and Economics - U.S. Department of Agriculture and Naomi Stevens, Head of Market Acceptance for BioScience at Bayer CropScience.

Small- to medium-sized biotechnology companies are bringing innovation to global health, according to a report published today by BIO Ventures for Global Health (BVGH) and BIO.

Jun 12 2012

Support Of Industry Underscores Pro-Business Commitment